iTonic Holdings Ltd (ITOC)
Nasdaq: ITOC · Electromedical & Electrotherapeutic Apparatus · Beijing · filing with the SEC since 2023
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 30, 2026 | Mar 20, 2025 | · | · |
| Revenue | 523,031 | 448,196 | 628,591 | 679,777 |
| Cost of revenue | 195,680 | 67,041 | 157,763 | 121,627 |
| Gross profit | 327,351 | 381,155 | 470,828 | 558,150 |
| Research and development | 459,135 | 93,324 | 84,474 | 73,717 |
| Sales and marketing | 181,853 | 307,534 | 268,135 | 294,856 |
| General and administrative | 4,873,326 | 750,563 | 424,899 | 162,056 |
| Total operating expenses | 5,514,314 | 1,151,421 | 777,508 | 530,629 |
| Operating income | -5,186,963 | -770,266 | -306,680 | 27,521 |
| Other income (expense), net | 66,309 | 23,198 | -1,996 | -3,502 |
| Total non-operating income (expense) | 88,579 | 131,507 | 46,172 | 43,506 |
| Income before income taxes | -5,098,384 | -638,759 | -260,508 | 71,027 |
| Income tax expense | · | 21,829 | -19,291 | -12,953 |
| Net income including non-controlling interests | -5,098,384 | -660,588 | -241,217 | · |
| Net income to non-controlling interests | -483 | · | · | · |
| Net income | -5,097,901 | -660,588 | -241,217 | 83,980 |
| Earnings per share, basic | -0.318 | -0.052 | -0.02 | 0.007 |
| Earnings per share, diluted | -0.318 | -0.052 | -0.02 | 0.007 |
| Weighted average shares, basic | 16,037,397 | 12,721,233 | 12,000,000 | 12,000,000 |
| Weighted average shares, diluted | 16,037,397 | 12,721,233 | 12,000,000 | 12,000,000 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding